ReShape Lifesciences, Inc. (RSLS): Market Cap to Revenue

Symbol and logo of brand ReShape Lifesciences Inc (RSLS)

ReShape Lifesciences (RSLS) develops minimally invasive systems to combat obesity, focusing on the bariatric segment. The median P/S confirms this trend, with the current parameter equal to 1.60. Business growth is constrained by the approval speed of new models and insurance limits. Margins are currently declining due to the expansion of modern weight-loss drugs, which creates significant risks for asset valuation.

RSLS ReShape Lifesciences Inc P/S Multiple (07/04/2022 - 08/30/2025)

Analytical breakdowns for ReShape Lifesciences (RSLS)

- share price and consensus valuation forecast:
Price Performance Chart reshapelifesciences.com|RSLS - Price Target Chart
- stock exchange capitalization data:
Market Valuation ReShape Lifesciences Inc|RSLS - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share ReShape Lifesciences|RSLS - Book Capitalization|Capitalization to Book Value Ratio reshapelifesciences.com|RSLS - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio reshapelifesciences.com|RSLS - Company Aggregate Debts|Debts to Book Capitalization ReShape Lifesciences Inc|RSLS - Company Long-Term Debt|Company Short-Term Debt ReShape Lifesciences|Intermediate Coverage Ratio reshapelifesciences.com
- earnings and multiples data:
RSLS - Net Profit|Expected Net Profit ReShape Lifesciences|RSLS - Price to Earnings Ratio|Forward Price to Earnings Multiple reshapelifesciences.com|RSLS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple ReShape Lifesciences Inc|RSLS - Operating profit EBITDA|Net earnings per share for the last four quarters ReShape Lifesciences|RSLS - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months reshapelifesciences.com|RSLS - Earnings per share growth in current year|Expected earnings per share growth for next year ReShape Lifesciences
- issuer revenue and sales details:
RSLS - Revenue and Sales Volume|Company Expected Sales Volume reshapelifesciences.com|RSLS - Price-to-Revenue Ratio|Market Cap to Projected Revenue ReShape Lifesciences Inc
General company analysis:RSLS ReShape Lifesciences, Inc.
Core merchandise of ReShape Lifesciences Inc.

The P/S multiple reflects the market value of ReShape Lifesciences (RSLS) relative to its annual sales volume, allowing investors to assess the premium paid per unit of revenue. By analyzing the current P/S valuation, the market weighs business growth rates against the costs of environmental upgrades to production lines and the implementation of recyclable packaging to determine the company's fundamental stability within the medical equipment sector.

Competitors of ReShape Lifesciences

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|beyondair.net (XAIR) - Price-to-Revenue Ratio|profusa.com - Market Capitalization-to-Revenue Ratio|SSKN (STRATA Skin Sciences Inc.) - P/S Multiple|Price to Sales glucotrack.com GCTK|Price-to-Revenue Ratio NanoVibronix (NAOV)|Price-to-Revenue Coefficient Venus Concept Corporation|P/S Multiple NUWE (Nuwellis, Inc.)|Market Capitalization-to-Revenue Ratio AEMD|TransEnterix - P/S Multiple|AVGR - P/S Multiple|BioSig Technologies, Inc (BSGM) - Price-to-Revenue Ratio|Price-to-Sales Ratio CUTR (Cutera Inc)|KNW (Know Labs, Inc.) - P/S Multiple|Price to Sales inarimedical.com NARI|Market Cap to Revenue NVRO (Nevro)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio